ACC 2018 | Risk of MI in Non-Cardiac Surgeries

One in five patients presenting perioperative MI during non-cardiac surgery should be readmitted within 30 days after surgery, and one in seven dies within the same period, according to the new study presented at ACC 2018 scientific sessions and simultaneously published in Circulation.

These infarctions could be considered a iatrogenic complication, given the obvious lack of proper cardiac assessment prior non-cardiac surgery.

More than 1000 patients undergoing perioperative MI (14%) died during hospitalization, compared to only 0.3% of MI in other contexts (p<0.001).

Those that survived hospitalization, despite perioperative MI, had three more chances of readmission within 30 days, vs. those without perioperative MI (19.1% vs 6.5%; p<0.001). These readmissions were due to infections (30%), cardiovascular complications (25.3%) and bleeding (10.4%).


Read also: ACC 2018 | SMART-DATE: 6 Month DAPT Results Suboptimal in ACS.


In those complicated with perioperative MI, mortality was different according to the type of non-cardiac surgery. The record was held by thoracic surgery, with 28.4% mortality rate, followed by general surgery 20.3%, vascular surgery with 15.3% and neurosurgery, with 12.5%.

Coronary revascularization was performed only in 15.8% of patients with perioperative MI, globally: 12.5% of NSTEMI patients were revascularized, vs. only 30.4% of STEMI patients. We should bear in mind that patients had been already been admitted when pain and ST elevation presented, and no action was taken in nearly 70% of cases.


Read also: ACC 2018 | SECURE-PCI: High Dose of Statins pior PCI Could Help.


Playing devil’s advocate, we could say that all these patients were already on painkillers and sedatives, which is why pain could have been disregarded. In addition, without pain to trigger an alarm, an ECG was also overlooked.

Original title: Hospital readmission following perioperative acute myocardial infarction associated with non-cardiac surgery.

Reference: Smilowitz NR et al. Circulation. 2018;Epub ahead of print.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Bioresorbable devices vs DES in patients at high risk of restenosis. Seven-year follow-up of the COMPARE-ABSORB trial

Studies with second-generation drug-eluting stents (DES) have shown that the rate of target lesion failure (TLF) increases linearly up to 5–10 years of follow-up,...

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

Rolling Stone: Registry of Intravascular Lithotripsy vs Atherectomy Use in Complex Calcified Lesions

Severe coronary calcification represents one of the main challenges in performing percutaneous coronary intervention, both due to the higher risk of stent underexpansion and...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Bioresorbable devices vs DES in patients at high risk of restenosis. Seven-year follow-up of the COMPARE-ABSORB trial

Studies with second-generation drug-eluting stents (DES) have shown that the rate of target lesion failure (TLF) increases linearly up to 5–10 years of follow-up,...

Low-Dose Rivaroxaban After Peripheral Angioplasty: Effectiveness and Safety in Real-World Clinical Practice

Following lower limb revascularization, optimal medical therapy includes antiplatelet agents, high-intensity statins, and control of cardiovascular risk factors. Recent studies such as COMPASS and...

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...